Product Details
Apidra 100 IU/mL Solution for Injection in a Vial**
Insulin glulisine1000 units/10 mL
Solution for injection
ROA
Subcutaneous
Applicant Name
Sanofi-Aventis Nigeria Limited
NRN
A6-0366
Status
Active
Composition
Apidra 100 Units/ml solution for injection in a vial. Each vial contains 10 mL of solution for injection, equivalent to 1000 Units. Each mL contains 100 Units insulin glulisine* (equivalent to 3.49 mg) *Insulin glulisine is produced by recombinant DNA technology in Escherichia coli
ATC Code
A10AB06
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 x 10 mL
Product Description
Solution for injection in a vial. Clear, colourless, aqueous solution
Manufacturer Name
Sanofi-Aventis Deutschland GmbH
Manufacturer Country
GERMANY
Approval Date
2022-12-18
Expiry Date
2027-12-17